Correction: Additive function of vibrio vulnificus MARTX Vv and VvhA cytolysins promotes rapid growth and epithelial tissue necrosis during intestinal infection (PLoS Pathogens (2012) 8:3 (e1002581) DOI: 10.1371/journal.ppat.1002581);Additive function of vibrio vulnificus MARTXVv and VvhA cytolysins promotes rapid growth and epithelial tissue necrosis during intestinal infection

PLoS Pathogens

Volumn 8, Issue 3, 2012, Pages

  Jeong, Hee Gon ^a   Satchell, Karla J F ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIN; MULTIFUNCTIONAL AUTOPROCESSING RTX TOXIN; UNCLASSIFIED DRUG; VVHA CYTOLYSIN; BACTERIAL PROTEIN; BACTERIAL TOXIN; HEMOLYSIN; VVHA PROTEIN, VIBRIO VULNIFICUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIUM ISOLATION; BIOLUMINESCENCE; CONTROLLED STUDY; ENTERITIS; HISTOPATHOLOGY; IMMUNE RESPONSE; INTESTINE INFECTION; MOUSE; NONHUMAN; SMALL INTESTINE; TISSUE INJURY; TISSUE NECROSIS; VIBRIO VULNIFICUS; ANIMAL; C57BL MOUSE; DISEASE MODEL; ENTEROPATHY; FEMALE; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; NECROSIS; PATHOGENICITY; PATHOLOGY;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS; VIBRIO VULNIFICUS;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CYTOTOXINS; DISEASE MODELS, ANIMAL; FEMALE; HEMOLYSIN PROTEINS; INTESTINAL DISEASES; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; NECROSIS; VIBRIO VULNIFICUS;

EID: 84861212995     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1007895     Document Type: Erratum

References (47)

1. Blake PA, Merson MH, Weaver RE, Hollis DG, Heublein PC, (1979) Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. N Engl J Med 300: 1-5.
2. Linkous DA, Oliver JD, (1999) Pathogenesis of Vibrio vulnificus. FEMS Microbiol Lett 174: 207-214.
3. Strom MS, Paranjpye RN, (2000) Epidemiology and pathogenesis of Vibrio vulnificus. Microbes Infect 2: 177-188.
4. Bowdre JH, Poole MD, Oliver JD, (1981) Edema and hemoconcentration in mice experimentally infected with Vibrio vulnificus. Infect Immun 32: 1193-1199.
5. Jones MK, Oliver JD, (2009) Vibrio vulnificus: disease and pathogenesis. Infect Immun 77: 1723-1733.
6. Chiang SR, Chuang YC, (2003) Vibrio vulnificus infection: clinical manifestations, pathogenesis, and antimicrobial therapy. J Microbiol Immunol Infect 36: 81-88.
7. Horseman MA, Surani S, (2011) A comprehensive review of Vibrio vulnificus: an important cause of severe sepsis and skin and soft-tissue infection. Int J Infect Dis 15: e157-166.
8. Tacket CO, Brenner F, Blake PA, (1984) Clinical features and an epidemiological study of Vibrio vulnificus infections. J Infect Dis 149: 558-561.
9. Thiaville PC, Bourdage KL, Wright AC, Farrell-Evans M, Garvan CW, et al. (2011) Genotype is correlated with but does not predict virulence of Vibrio vulnificus biotype 1 in subcutaneously inoculated, iron dextran-treated mice. Infect Immun 79: 1194-1207.
10. Daniels NA, (2011) Vibrio vulnificus oysters: pearls and perils. Clin Infect Dis 52: 788-792.
11. Gulig PA, Bourdage KL, Starks AM, (2005) Molecular Pathogenesis of Vibrio vulnificus. J Microbiol 43 Spec No: 118-131.
12. Fan JJ, Shao CP, Ho YC, Yu CK, Hor LI, (2001) Isolation and characterization of a Vibrio vulnificus mutant deficient in both extracellular metalloprotease and cytolysin. Infect Immun 69: 5943-5948.
13. Chung KJ, Cho EJ, Kim MK, Kim YR, Kim SH, et al. (2010) RtxA1-induced expression of the small GTPase Rac2 plays a key role in the pathogenicity of Vibrio vulnificus. J Infect Dis 201: 97-105.
14. Kim YR, Lee SE, Kook H, Yeom JA, Na HS, et al. (2008) Vibrio vulnificus RTX toxin kills host cells only after contact of the bacteria with host cells. Cell Microbiol 10: 848-862.
15. Kwak JS, Jeong HG, Satchell KJ, (2011) Vibrio vulnificus rtxA1 gene recombination generates toxin variants with altered potency during intestinal infection. Proc Natl Acad Sci U S A 108: 1645-1650.
16. Kim JR, Oh DR, Cha MH, Pyo BS, Rhee JH, et al. (2008) Protective effect of polygoni cuspidati radix and emodin on Vibrio vulnificus cytotoxicity and infection. J Microbiol 46: 737-743.
17. Lee JH, Kim MW, Kim BS, Kim SM, Lee BC, et al. (2007) Identification and characterization of the Vibrio vulnificus rtxA essential for cytotoxicity in vitro and virulence in mice. J Microbiol 45: 146-152.
18. Liu M, Alice AF, Naka H, Crosa JH, (2007) The HlyU protein is a positive regulator of rtxA1, a gene responsible for cytotoxicity and virulence in the human pathogen Vibrio vulnificus. Infect Immun 75: 3282-3289.
19. Lo HR, Lin JH, Chen YH, Chen CL, Shao CP, et al. (2011) RTX toxin enhances the survival of Vibrio vulnificus during infection by protecting the organism from phagocytosis. J Infect Dis 203: 1866-1874.
20. Shinoda S, Miyoshi S, Yamanaka H, Miyoshi-Nakahara N, (1985) Some properties of Vibrio vulnificus hemolysin. Microbiol Immunol 29: 583-590.
21. Toma C, Higa N, Koizumi Y, Nakasone N, Ogura Y, et al. (2010) Pathogenic Vibrio activate NLRP3 inflammasome via cytotoxins and TLR/nucleotide-binding oligomerization domain-mediated NF-kappa B signaling. J Immunol 184: 5287-5297.
22. Yamamoto K, Wright AC, Kaper JB, Morris JG Jr, (1990) The cytolysin gene of Vibrio vulnificus: sequence and relationship to the Vibrio cholerae E1 Tor hemolysin gene. Infect Immun 58: 2706-2709.
23. Wright AC, Morris JG Jr, (1991) The extracellular cytolysin of Vibrio vulnificus: inactivation and relationship to virulence in mice. Infect Immun 59: 192-197.
24. Morin CE, Kaper JB, (2009) Use of stabilized luciferase-expressing plasmids to examine in vivo-induced promoters in the Vibrio cholerae vaccine strain CVD 103-HgR. FEMS Immunol Med Microbiol 57: 69-79.
25. Pineyro P, Zhou X, Orfe LH, Friel PJ, Lahmers K, et al. (2010) Development of two animal models to study the function of Vibrio parahaemolyticus type III secretion systems. Infect Immun 78: 4551-4559.
26. Starks AM, Bourdage KL, Thiaville PC, Gulig PA, (2006) Use of a marker plasmid to examine differential rates of growth and death between clinical and environmental strains of Vibrio vulnificus in experimentally infected mice. Mol Microbiol 61: 310-323.
27. Chen Y, Satoh T, Tokunaga O, (2002) Vibrio vulnificus infection in patients with liver disease: report of five autopsy cases. Virchows Arch 441: 88-92.
28. Shirouzu K, Miyamoto Y, Yasaka T, Matsubayashi Y, Morimatsu M, (1985) Vibrio vulnificus septicemia. Acta Pathol Jpn 35: 731-739.
29. Tajiri T, Tate G, Akita H, Ohike N, Masunaga A, et al. (2008) Autopsy cases of fulminant-type bacterial infection with necrotizing fasciitis: group A (beta) hemolytic Streptococcus pyogenes versus Vibrio vulnificus infection. Pathol Int 58: 196-202.
30. Hor LI, Chang TT, Wang ST, (1999) Survival of Vibrio vulnificus in whole blood from patients with chronic liver diseases: association with phagocytosis by neutrophils and serum ferritin levels. J Infect Dis 179: 275-278.
31. Shin SH, Shin DH, Ryu PY, Chung SS, Rhee JH, (2002) Proinflammatory cytokine profile in Vibrio vulnificus septicemic patients' sera. FEMS Immunol Med Microbiol 33: 133-138.
32. Fink SL, Cookson BT, (2007) Pyroptosis and host cell death responses during Salmonella infection. Cell Microbiol 9: 2562-2570.
33. Winter SE, Baumler AJ, (2011) A breathtaking feat: to compete with the gut microbiota, Salmonella drives its host to provide a respiratory electron acceptor. Gut Microbes 2: 58-60.
34. Winter SE, Thiennimitr P, Winter MG, Butler BP, Huseby DL, et al. (2010) Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 467: 426-429.
35. Chen CY, Wu KM, Chang YC, Chang CH, Tsai HC, et al. (2003) Comparative genome analysis of Vibrio vulnificus, a marine pathogen. Genome Res 13: 2577-2587.
36. Gulig PA, de Crecy-Lagard V, Wright AC, Walts B, Telonis-Scott M, et al. (2010) SOLiD sequencing of four Vibrio vulnificus genomes enables comparative genomic analysis and identification of candidate clade-specific virulence genes. BMC Genomics 11: 512.
37. Kim DM, Jung SI, Jang HC, Lee CS, Lee SH, et al. (2011) Vibrio vulnificus DNA load and mortality. J Clin Microbiol 49: 413-415.
38. Lee JY, Kim DM, Yun NR, Neupane GP, Jung SI, et al. (2011) Tumor necrosis factor-alpha and mortality in patients infected with Vibrio vulnificus. Am J Trop Med Hyg 84: 426-428.
39. Wongpaitoon V, Sathapatayavongs B, Prachaktam R, Bunyaratvej S, Kurathong S, (1985) Spontaneous Vibrio vulnificus peritonitis and primary sepsis in two patients with alcoholic cirrhosis. Am J Gastroenterol 80: 706-708.
40. Roig FJ, Gonzalez-Candelas F, Amaro C, (2011) Domain organization and evolution of multifunctional autoprocessing repeats-in-toxin (MARTX) toxin in Vibrio vulnificus. Appl Environ Microbiol 77: 657-668.
41. Cohen AL, Oliver JD, DePaola A, Feil EJ, Boyd EF, (2007) Emergence of a virulent clade of Vibrio vulnificus and correlation with the presence of a 33-kilobase genomic island. Appl Environ Microbiol 73: 5553-5565.
42. Fullner KJ, Mekalanos JJ, (1999) Genetic characterization of a new type IV-A pilus gene cluster found in both classical and El Tor biotypes of Vibrio cholerae. Infect Immun 67: 1393-1404.
43. Philippe N, Alcaraz JP, Coursange E, Geiselmann J, Schneider D, (2004) Improvement of pCVD442, a suicide plasmid for gene allele exchange in bacteria. Plasmid 51: 246-255.
44. Olivier V, Queen J, Satchell KJ, (2009) Successful small intestine colonization of adult mice by Vibrio cholerae requires ketamine anesthesia and accessory toxins. PLoS One 4: e7352.
45. Reed L, Muench H, (1938) A simple method of estimating fifty percent endpoints. Amer J Hygiene 27: 493-497.
46. Miller VL, Mekalanos JJ, (1988) A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol 170: 2575-2583.
47. Simon R, Priefer U, Puhler A, (1983) A Broad Host Range Mobilization System for Invivo Genetic-Engineering- Transposon Mutagenesis in Gram-Negative Bacteria. Bio-Technology 1: 784-791.